Long-Term Assets: The sum of all assets classified as non-current.
Hikma Pharmaceuticals Plc (HKMPF) had Long-Term Assets of $4.16B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.64B |
|
$2.58B |
|
|
Long-Term Assets |
$4.16B |
$5.67B |
|
$1.45B |
|
$1.49B |
|
$1.61B |
|
$3.06B |
|
$2.61B |
|
$1.44B |
|
$2.61B |
|
-- |
|
| Cash Flow Statement Financials | |
$436.00M |
|
$-388.00M |
|
$-25.00M |
|
$188.00M |
|
$217.00M |
|
$29.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|